Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


33rd Annual Cardiologists Conference

London, UK

Pritha Bhattacharjee

Pritha Bhattacharjee

University of Calcutta, India

Notice: Undefined index: speaker_title in /var/www/universal_code/abstract-details.php on line 208
Title: Environmental epigenetics in population exposed to chronic arsenic & Cancer


Biography: Pritha Bhattacharjee


Chronic arsenic exposure and its cancer association is already known. Our study explored the epigenetic perspectives of arsenic toxicity. The major investigations we performed include DNA damage response, telomere regulation, arsenic methylation and mitochondrial biogenesis. Our novel findings are to identify signature patterns for arsenic exposure (compared to those who are unexposed) and arsenic-induced characteristic lesion (compared to arsenic exposed No Skin Lesion group). Although arsenic induced skin lesions are hallmarks of arsenic toxicity, it is observed only among15-20% of the exposed population. This clearly indicates environment and gene crosstalk each other with significant variation at population level. We have identified alteration in DNA methylation pattern for the candidate genes, histone post translational modifications and also differential miRNA regulation. Among all different pathways, most critical is the arsenic metabolism pathway. This metabolism depends on the efficiency of arsenic methylation, which is further dependant on methylation donor SAM (S-Adenosyl L-methionine) level and enzyme activity of AS3MT (Arsenite methyltransferase). Our study identified how arsenic depletes SAM level and affect overall metabolism leading to arsenic susceptibility. Mitochondrial biogenesis also play a significant role, where regulatory genes including PGC1α, Tfam, NRF1 and NRF2 were upregulated among arsenic induced cancer patients via promoter hypomethylation. Thus, our study considers a holistic approach to understand the epigenetic interplay in the individuals having prolonged arsenic exposure history.